Multimarker strategy for risk prediction in patients presenting with acute dyspnea to the emergency department

International Journal of Cardiology

Volumn 126, Issue 1, 2008, Pages 73-78

  Christ, Michael ^a   Laule, Kirsten ^a   Klima, Theresia ^a   Hochholzer, Willibald ^a   Breidthardt, Tobias ^a   Perruchoud, Andre P ^a   Mueller, Christian ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Acute dyspnea; C reactive protein; Mortality; Natriuretic peptides; Prognosis; Troponin I

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; DEATH; DYSPNEA; EMERGENCY WARD; FEMALE; FOLLOW UP; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; UNIVARIATE ANALYSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIAGNOSIS, DIFFERENTIAL; DYSPNEA; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; SINGLE-BLIND METHOD; TROPONIN I;

EID: 41949090688     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.03.119     Document Type: Article

References (27)

1. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
2. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
3. Anonymous. Dyspnea. Mechanisms, assessment, and management: a consensus statement. American Thoracic Society. Am J Respir Crit Care Med 159 (1999) 321-340
4. Fonarow G.C., Adams Jr. K.F., Abraham W.T., Yancy C.W., and Boscardin W.J. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293 (2005) 572-580
5. McCullough P.A., Nowak R.M., McCord J., et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from Breathing Not Properly (BNP) Multinational Study. Circulation 106 (2002) 416-422
6. de Lemos J.A., Morrow D.A., Bentley J.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
7. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 (2000) 1139-1147
8. Mueller C., Buettner H.J., Hodgson J.M., et al. Inflammation and long-term mortality after non-ST elevation acute coronary syndrome treated with a very early invasive strategy in 1042 consecutive patients. Circulation 105 (2002) 1412-1415
9. Sabatine M.S., Morrow D.A., de Lemos J.A., et al. Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 105 (2002) 1760-1763
10. Doust J.A., Pietrzak E., Dobson A., and Glasziou P. How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review. BMJ 330 (2005) 625
11. Rudiger A., Harjola V.P., Muller A., et al. Acute heart failure: clinical presentation, one-year mortality and prognostic factors. Eur J Heart Fail 7 (2005) 662-670
12. Mueller C., Laule-Kilian K., Christ A., Brunner-La Rocca H.P., and Perruchoud A.P. Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 151 (2006) 845-850
13. Bruneau B.G., Piazza L.A., and de Bold A.J. BNP gene expression is specifically modulated by stretch and ET-1 in a new model of isolated rat atria. Am J Physiol 273 (1997) H2678-H2686
14. Adams III J.E., Bodor G.S., Davila-Roman V.G., et al. Cardiac troponin I. A marker with high specificity for cardiac injury. Circulation 88 (1993) 101-106
15. Felker G.M., and Cotter G. Unraveling the pathophysiology of acute heart failure: an inflammatory proposal. Am Heart J 151 (2006) 765-767
16. Cheng V., Kazanagra R., Garcia A., et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 37 (2001) 386-391
17. Apple F.S., Wu A.H., and Jaffe A.S. European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials. Am Heart J 144 (2002) 981-986
18. Mueller C., Laule-Kilian K., Scholer A., et al. Use of B-type natriuretic peptide for the management of women with dyspnea. Am J Cardiol 94 (2004) 1510-1514
19. Konstantinides S., Geibel A., Olschewski M., et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism. Circulation 106 (2002) 1263-1268
20. Wang C.S., FitzGerald J.M., Schulzer M., Mak E., and Ayas N.T. Does this dyspneic patient in the emergency department have congestive heart failure?. JAMA 294 (2005) 1944-1956
21. Fonseca C, Morais H, Mota T, et al. The diagnosis of heart failure in primary care: value of symptoms and signs. Eur J Heart Fail 2004; 6:795-800, 821-792.
22. Antman E.M. Decision making with cardiac troponin tests. N Engl J Med 346 (2002) 2079-2082
23. Gegenhuber A., Mueller T., Firlinger F., et al. Time course of B-type natriuretic peptide (BNP) and N-terminal proBNP changes in patients with decompensated heart failure. Clin Chem 50 (2004) 454-456
24. Missov E., and Mair J. A novel biochemical approach to congestive heart failure: cardiac troponin T. Am Heart J 138 (1999) 95-99
25. Perna E.R., Macin S.M., Parras J.I., et al. Cardiac troponin T levels are associated with poor short- and long-term prognosis in patients with acute cardiogenic pulmonary edema. Am Heart J 143 (2002) 814-820
26. Mann D.L. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91 (2002) 988-998
27. Pratt C.M., Greenway P.S., Schoenfeld M.H., Hibben M.L., and Reiffel J.A. Exploration of the precision of classifying sudden cardiac death. Implications for the interpretation of clinical trials. Circulation 93 (1996) 519-524